missing translation for 'onlineSavingsMsg'
Learn More

FBXO17 Mouse, anti-Human, CoraLite Plus 488, Clone: 1F3D3, Proteintech

Mouse Monoclonal Antibody

£135.00 - £375.00

Specifications

Antigen FBXO17
Clone 1F3D3
Concentration 1000 μg/mL
Applications Immunofluorescence
Conjugate CoraLite Plus 488
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18019495
View Documents
Proteintech
CL488-68246-100UL
100 μL
£375.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18075195
View Documents
Proteintech
CL488-68246-20UL
20 μL
£135.00
20µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The FBXO17 antibody from Proteintech is a mouse monoclonal antibody generated with recombinant protein of human FBXO17. This antibody recognizes human antigen. The FBXO17 antibody has been validated for the following applications: IF analysis. This antibody is coralite™ plus 488.

Specifications

Specifications

FBXO17
1000 μg/mL
CoraLite Plus 488
Mouse
115290
IgG1
Store at -20°C. Avoid exposure to light. Stable for one year after shipment.
1F3D3
Immunofluorescence
Liquid
Human
F box only protein 17, F box only protein 26, F box protein 17, FBG4, Fbx17, FBX26, FBXO17, FBXO26, FLJ11798, FLJ25205, FLJ58300
Primary
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.